News

Abeona Therapeutics' Zevaskyn, a cell therapy based on engineered keratinocytes harvested from patients, has been approved in the US as a treatment for the rare skin disorder recessive dystrophic ...
Switzerland-based biopharma start-up Enzyvant has gained a double fast track status from the FDA for its new rare disease candidate RVT-802. The investigational tissue-based therapy is for the ...
Users can only store 20 items on their mobile devices before having to delete or send them to their accounts. CAUTION: You can not get back Golden Keys once they're used, even if you back out of ...
Advancement of Nolans Project engineering and design; Advancement of Nolans Project funding and offtake negotiations; Social and environmental studies and evaluations on the Project; and Mineral ...